Exact Sciences Stock Market Value
| EXAS Stock | USD 103.36 0.05 0.05% |
| Symbol | EXACT |
Is there potential for Biotechnology market expansion? Will EXACT introduce new products? Factors like these will boost the valuation of EXACT Sciences. Projected growth potential of EXACT fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share | Quarterly Revenue Growth 0.231 | Return On Assets | Return On Equity |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between EXACT Sciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EXACT Sciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, EXACT Sciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
EXACT Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to EXACT Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of EXACT Sciences.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in EXACT Sciences on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding EXACT Sciences or generate 0.0% return on investment in EXACT Sciences over 90 days. EXACT Sciences is related to or competes with Guardant Health, ICON PLC, Viatris, BridgeBio Pharma, Summit Therapeutics, Revvity, and Roivant Sciences. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and international... More
EXACT Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure EXACT Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess EXACT Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.3398 | |||
| Information Ratio | 0.1782 | |||
| Maximum Drawdown | 24.01 | |||
| Value At Risk | (0.23) | |||
| Potential Upside | 0.5065 |
EXACT Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for EXACT Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as EXACT Sciences' standard deviation. In reality, there are many statistical measures that can use EXACT Sciences historical prices to predict the future EXACT Sciences' volatility.| Risk Adjusted Performance | 0.1591 | |||
| Jensen Alpha | 0.6853 | |||
| Total Risk Alpha | 0.508 | |||
| Sortino Ratio | 1.87 | |||
| Treynor Ratio | (2.11) |
EXACT Sciences February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1591 | |||
| Market Risk Adjusted Performance | (2.10) | |||
| Mean Deviation | 1.28 | |||
| Downside Deviation | 0.3398 | |||
| Coefficient Of Variation | 522.94 | |||
| Standard Deviation | 3.57 | |||
| Variance | 12.78 | |||
| Information Ratio | 0.1782 | |||
| Jensen Alpha | 0.6853 | |||
| Total Risk Alpha | 0.508 | |||
| Sortino Ratio | 1.87 | |||
| Treynor Ratio | (2.11) | |||
| Maximum Drawdown | 24.01 | |||
| Value At Risk | (0.23) | |||
| Potential Upside | 0.5065 | |||
| Downside Variance | 0.1155 | |||
| Semi Variance | (0.63) | |||
| Expected Short fall | (1.24) | |||
| Skewness | 5.68 | |||
| Kurtosis | 32.76 |
EXACT Sciences Backtested Returns
Currently, EXACT Sciences is very steady. EXACT Sciences retains Efficiency (Sharpe Ratio) of 0.24, which denotes the company had a 0.24 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for EXACT Sciences, which you can use to evaluate the volatility of the firm. Please confirm EXACT Sciences' Standard Deviation of 3.57, coefficient of variation of 522.94, and Market Risk Adjusted Performance of (2.10) to check if the risk estimate we provide is consistent with the expected return of 0.041%. EXACT Sciences has a performance score of 18 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of -0.32, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning EXACT Sciences are expected to decrease at a much lower rate. During the bear market, EXACT Sciences is likely to outperform the market. EXACT Sciences now owns a risk of 0.17%. Please confirm EXACT Sciences standard deviation, expected short fall, relative strength index, as well as the relationship between the maximum drawdown and rate of daily change , to decide if EXACT Sciences will be following its current price history.
Auto-correlation | 0.64 |
Good predictability
EXACT Sciences has good predictability. Overlapping area represents the amount of predictability between EXACT Sciences time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of EXACT Sciences price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current EXACT Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.